Dallas Jayson Donald Alexander - Net Worth and Insider Trading
Dallas Jayson Donald Alexander Net Worth
The estimated net worth of Dallas Jayson Donald Alexander is at least $5 Million dollars as of 2024-11-13. Dallas Jayson Donald Alexander is the President and CEO of Aimmune Therapeutics Inc and owns about 123,283 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $4 Million. Dallas Jayson Donald Alexander is also the Director of Arena Pharmaceuticals Inc and owns about 7,152 shares of Arena Pharmaceuticals Inc (ARNA) stock worth over $715,128. Details can be seen in Dallas Jayson Donald Alexander's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dallas Jayson Donald Alexander has not made any transactions after 2021-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dallas Jayson Donald Alexander
Dallas Jayson Donald Alexander Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dallas Jayson Donald Alexander owns 4 companies in total, including Aimmune Therapeutics Inc (AIMT) , Arena Pharmaceuticals Inc (ARNA) , and Ultragenyx Pharmaceutical Inc (RARE) among others .
Click here to see the complete history of Dallas Jayson Donald Alexander’s form 4 insider trades.
Insider Ownership Summary of Dallas Jayson Donald Alexander
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-10 | director & President and CEO |
| ARNA | Arena Pharmaceuticals Inc | 2021-06-15 | director |
| RARE | Ultragenyx Pharmaceutical Inc | 2015-08-03 | See Remarks |
 | | 2020-11-19 | director |
Dallas Jayson Donald Alexander Latest Holdings Summary
Dallas Jayson Donald Alexander currently owns a total of 2 stocks. Among these stocks, Dallas Jayson Donald Alexander owns 123,283 shares of Aimmune Therapeutics Inc (AIMT) as of March 10, 2020, with a value of $4 Million and a weighting of 85.6%. Dallas Jayson Donald Alexander also owns 7,152 shares of Arena Pharmaceuticals Inc (ARNA) as of June 15, 2021, with a value of $715,128 and a weighting of 14.4%.
Latest Holdings of Dallas Jayson Donald Alexander
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-03-10 | 123,283 | 34.49 | 4,252,031 |
| ARNA | Arena Pharmaceuticals Inc | 2021-06-15 | 7,152 | 99.99 | 715,128 |
Holding Weightings of Dallas Jayson Donald Alexander
Dallas Jayson Donald Alexander Form 4 Trading Tracker
According to the SEC Form 4 filings, Dallas Jayson Donald Alexander has made a total of 1 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 2,665 shares on March 10, 2020, which cost Dallas Jayson Donald Alexander around $49,942.
According to the SEC Form 4 filings, Dallas Jayson Donald Alexander has made a total of 4 transactions in Arena Pharmaceuticals Inc (ARNA) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Arena Pharmaceuticals Inc is the sale of 1,223 shares on June 15, 2021, which brought Dallas Jayson Donald Alexander around $81,158.
Insider Trading History of Dallas Jayson Donald Alexander
- 1
Dallas Jayson Donald Alexander Trading Performance
GuruFocus tracks the stock performance after each of Dallas Jayson Donald Alexander's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dallas Jayson Donald Alexander is -1.32%. GuruFocus also compares Dallas Jayson Donald Alexander's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dallas Jayson Donald Alexander within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dallas Jayson Donald Alexander's insider trading performs compared to the benchmark.
Performance of Dallas Jayson Donald Alexander
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.99 | | | | | |
| Relative Return to S&P 500(%) | -3.23 | | | | | |
Dallas Jayson Donald Alexander Ownership Network
Ownership Network List of Dallas Jayson Donald Alexander
Ownership Network Relation of Dallas Jayson Donald Alexander
Dallas Jayson Donald Alexander Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Dallas Jayson Donald Alexander is the director & President and CEO of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Dallas Jayson Donald Alexander Mailing Address
Above is the net worth, insider trading, and ownership report for Dallas Jayson Donald Alexander. You might contact Dallas Jayson Donald Alexander via mailing address: Aimmune Therapeutics, Inc., 8000 Marina Boulevard, Suite 300, Brisbane Ca 94005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
